NDC product
Amoxicillin/Clav Pot Oral Susp
NDC 72189-367 · Direct_Rx
Key facts
| Product NDC | 72189-367 |
|---|---|
| Proprietary name | Amoxicillin/Clav Pot Oral Susp |
| Nonproprietary name | Amoxicillin/Clav Pot Oral Susp |
| Substances | AMOXICILLIN, CLAVULANATE POTASSIUM |
| Dosage form | POWDER, FOR SUSPENSION |
| Route | ORAL |
| Labeler | Direct_Rx |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA201090 |
| Pharmacologic classes | Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
| Marketing start | Aug 8, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: